Arthralgia: Clinical Trials

53 trials for Arthralgia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

31 completed, 11 unknown, 5 terminated, 3 recruiting. 53 Phase 3, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 353Completed 31, Unknown 11, Terminated 5, Recruiting 3, Withdrawn 2, Active not recruiting 1
Phase 26Unknown 3, Recruiting 2, Completed 1

Follow Arthralgia: new trials by email Literature Review of Arthralgia trials Research Report on Arthralgia

Trials (filtered) newest first · largest first

All 53 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Population
Maolactin, Maltodextrin - Chronic Inflammation, Mobility
Phase 3CompletedRDC Clinical Pty Ltd972025-02-272026-03-06
Efficacy and Safety of Celecoxib/Acetaminophen Versus Celecoxib for Diagnosed Osteoarthritis in Acute Exacerbation
Celecoxib + Acetaminophen, Celecoxib - Joint Pain, Knee Osteoarthritis
Phase 3CompletedLaboratorios Silanes S.A. de C.V.2312024-09-092026-10-23
The MUSE Study for Menopausal Arthralgia
Menopausal hormone therapy, Exercise training, Menopausal hormone therapy + exercise training - Arthralgia, Menopause
Phase 2 / Phase 3RecruitingNational University Hospital, Singapore1002024-08-012024-07-31
Intra-articular Corticosteroids Are Widely Used for Adhesive Capsulitis, But Alternatives Are Required for Patients With Contraindications. Hyaluronic Acid (HA) and Ketorolac Have Shown Individual Benefits. However, Evidence on Their Combination Remains Limited.
Intra-articular Hyaluronic Acid and Ketorolac, Intra-articular Ketorolac - Adhesive Capsulitis of the Shoulder
Phase 3CompletedMahidol University562023-11-012025-09-25
Analysis of the Effect of Neuromuscular Electro-stimulation on the Performance of Isometric Rotator Cuff Strength.
STRENGTH EVALUATION WITH ELECTROSTIMULATOR, STRENGTH EVALUATION WITHOUT ELECTROSTIMULATOR - Rotator Cuff Impingement Syndrome, Rotator Cuff Tendinitis
Phase 2 / Phase 3UnknownUniversity of Campinas, Brazil602023-09-012023-09-05
Topical Treatment for TMJ Arthralgia
Hydrocortisone 2.5%, Diclofenac 1% topical - TMJ Pain
Phase 3RecruitingUniversity of the Pacific902023-06-012024-12-11
Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia
Online Pain Coping Skills Training, Education - Breast Cancer, Arthralgia
Phase 3Active not recruitingNorthwestern University4522023-01-192026-10-29
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
Dapansutrile, Placebo Tablet - Acute Gout Flare, Gout Attack
Phase 2 / Phase 3RecruitingOlatec Therapeutics, Inc.3002023-01-062026-03-11
Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy
TRM-201 (Rofecoxib), Placebo - Hemophilic Arthropathy
Phase 3TerminatedTremeau Pharmceuticals, Inc.22021-06-022022-10-27
Pain Management After Shoulder Arthroplasty
Total Shoulder Arthroplasty, Caffeine Pill, Percocet 10Mg-325Mg Tablet - Caffeine, Pain, Joint
Phase 3UnknownRothman Institute Orthopaedics1602021-04-152021-05-04
Saphenous Nerve Block for Partial Meniscectomy
Saphenous Nerve Block, Ropivacaine injection - Pain, Joint, Pain, Procedural
Phase 3UnknownRothman Institute Orthopaedics1602021-01-252021-01-22
Does Meloxicam Provide as Much Pain Relief as Opioids After Shoulder Surgery?
Meloxicam 15 mg, Preoperative Interscalene Nerve Block, arthroscopic labral repair - Shoulder Pain
Phase 3UnknownRothman Institute Orthopaedics962021-01-252021-01-26
Comparative Study of Turmeric Extract in Patients With Arthrosis.
Placebo, Turmeric - Arthralgia, Stiffness of Unspecified Joint, Not Elsewhere Classified
Phase 3CompletedKaj Winther Hansen1202020-01-012021-10-25
Effect of Intravenous Dexmedetomidine on Patient Discomfort in Laparoscopic Cholecystectomy Under Spinal Anesthesia.
Dexmedetomidine, normal saline - Shoulder Pain
Phase 2 / Phase 3UnknownTheodor Bilharz Research Institute402019-11-152021-04-02
Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy
Gabapentin 300mg - Invasive Breast Cancer, Chemotherapeutic Toxicity
Phase 2 / Phase 3UnknownBritish Columbia Cancer Agency462018-07-022018-06-25
Multimodal Analgesia in Shoulder Arthroplasty
Acetaminophen, Celecoxib 200mg, Celecoxib 400 mg - Shoulder Pain, Opioid Use
Phase 3WithdrawnRush University Medical Center2018-06-012021-09-28
Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA
Canakinumab - Systemic Juvenile Idiopathic Arthritis
Phase 3CompletedNovartis Pharmaceuticals192015-05-072019-09-13
ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection
DTG 50 mg /ABC 600 mg /3TC 300 mg FDC tablets - Infection, Human Immunodeficiency Virus, HIV Infections
Phase 3CompletedViiV Healthcare42014-12-172022-10-06
ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab
ACZ885 150 mg (Canakinumab) - Systemic Juvenile Idiopathic Arthritis (SJIA)
Phase 3CompletedNovartis Pharmaceuticals1822014-11-172019-07-09
A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies
canakinumab - Systemic Juvenile Idiopathic Arthritis, Hereditary Periodic Fevers
Phase 3CompletedNovartis Pharmaceuticals312014-11-032020-05-19

Showing 20 of 53. Sign in to see all of them.

Narrower conditions

Shoulder Pain (19)  ·  Pain (16)  ·  Arthritis (5)  ·  Myalgia (5)  ·  Arthritis, Juvenile (4)  ·  Bursitis (4)  ·  Osteoarthritis (4)  ·  Acute Pain (3)  ·  Breast Neoplasms (3)  ·  Bronchiolitis Obliterans Syndrome (3)  ·  Cartilage Diseases (3)  ·  Chronic Pain (3)  ·  Fibromyalgia (3)  ·  Motor Activity (3)

Broader conditions

Musculoskeletal Diseases (53)  ·  Neurologic Manifestations (53)  ·  Pathological Conditions, Signs and Symptoms (53)  ·  Signs and Symptoms (53)  ·  Joint Diseases (51)  ·  Pain (37)  ·  Rheumatic Diseases (15)  ·  Nervous System Diseases (11)  ·  Skin and Connective Tissue Diseases (11)  ·  Muscular Diseases (10)  ·  Arthritis (9)  ·  Connective Tissue Diseases (8)  ·  Neuromuscular Diseases (7)  ·  Wounds and Injuries (7)

Interventions

Tapentadol (4)  ·  Sodium Oxybate (3)  ·  canakinumab (3)  ·  Acetaminophen (2)  ·  Celecoxib (2)  ·  Control Groups (2)  ·  Exercise (2)  ·  Ketorolac (2)  ·  Meloxicam (2)  ·  Morphine (2)  ·  Oxycodone (2)  ·  Ropivacaine (2)  ·  oxycodone-acetaminophen (2)  ·  Abatacept (1)  ·  Arthroplasty, Replacement, Shoulder (1)

Sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (6)  ·  Jazz Pharmaceuticals (3)  ·  Novartis Pharmaceuticals (3)  ·  Rothman Institute Orthopaedics (3)  ·  Alkemira SA (2)  ·  Taipei Veterans General Hospital, Taiwan (2)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Amgen (1)  ·  British Columbia Cancer Agency (1)  ·  Hisamitsu Pharmaceutical Co., Inc. (1)  ·  IDEA AG (1)  ·  Imprimis Pharmaceuticals, Inc. (1)  ·  Kaj Winther Hansen (1)  ·  Laboratorios Silanes S.A. de C.V. (1)  ·  Lifespan (1)

Countries

United States (28)  ·  Spain (7)  ·  France (5)  ·  Germany (5)  ·  Canada (4)  ·  Italy (4)  ·  Netherlands (4)  ·  Australia (3)  ·  Poland (3)  ·  United Kingdom (3)  ·  Belgium (2)  ·  Israel (2)  ·  Russia (2)  ·  Sweden (2)  ·  Taiwan (2)

Top investigators

Hsiao-Wen Tsai, M.D. (2)  ·  Adelfia Urenda-Quezada, MD (1)  ·  Alessandro Ugolini, DDS (1)  ·  Andrew Forbes (1)  ·  Anthony Harris (1)  ·  Charles Loprinzi, MD (1)  ·  David Briskey, PhD (1)  ·  Dawn Hershman, MD (1)  ·  Eugenia Rota, MD (1)  ·  Franco Mongini, Professor (1)  ·  Geoffrey W Wilson, M.D. (1)

Results publications

PMID 16331769, PMID 17043939, PMID 17761004, PMID 18448749, PMID 19116896, PMID 19203298, PMID 19301989, PMID 19445652, PMID 19755551, PMID 20530557, PMID 20863369, PMID 21075272, PMID 21088117, PMID 21174485, PMID 21248398, PMID 21397402, PMID 21494892, PMID 21904098, PMID 22059194, PMID 22184293, PMID 23635614, PMID 24286114, PMID 25940724, PMID 26695349, PMID 27477473, PMID 28257617, PMID 29417082, PMID 31353997, PMID 32086778, PMID 32313809, PMID 32372176, PMID 32552266, PMID 32783351, PMID 34524031, PMID 35241100, PMID 36300352, PMID 39353107, PMID 39706331

NIH funding

2014 (1), 2018 (1), 2023 (1), R01CA271220 (1), U10CA037429 (1), U10CA037447 (1), UG1CA189823 (1)